Definiens and ACD Introduce RNAscope SpotStudio™|
Tuesday, May 21, 2013
Quantitative biomarker analysis advanced by alliance between ACD and Definiens, providers of breakthrough platform for in situ RNA biomarker detection and leading image analysis technology for digital pathology.
Abbott Announces CE Mark for ARCHITECT Clinical Chemistry HbA1c Test
Monday, May 13, 2013
CE marking for test to aid doctors with diagnosing and monitoring diabetes.
Radiometer’s POC Analyzers Help to Evolve Pathology Services in Cornwall
Friday, May 10, 2013
The ABL800, ABL90 and AQT90 FLEX helps to meet diagnostic testing demands in remote locations.
Randox Licenses sPLA2 CVD Risk Test from Aterovax
Thursday, May 02, 2013
Partnership to develop Aterovax’s patented biomarker sPLA2 for the assessment of cardiovascular risk.
A*STAR and Veredus Announces Launch of VereTrop™
Friday, April 26, 2013
First lab-on-chip for the detection of multiple tropical infectious diseases.